Liminatus Pharma Inc Cl A (LIMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 1,149 | 701 | 1,118 | 0 | 1,878 |
| Operating Income | -1,148 | -701 | -1,118 | 0 | -1,878 |
| Interest Expense | 135 | 19 | 62 | 0 | 169 |
| Other Income | -7,214 | -1,103 | 1,294 | 1 | 63 |
| Pre-tax Income | -8,497 | -1,823 | 113 | 0 | -1,984 |
| Net Income Continuous | -8,497 | -1,823 | 113 | 0 | -1,984 |
| Net Income | $-8,497 | $-1,823 | $113 | $0 | $-1,984 |
| EPS Basic Total Ops | 2.19 | -0.07 | 0.00 | -2.55 | 2.35 |
| EPS Basic Continuous Ops | -2.92 | -0.07 | 0.00 | 2.55 | -2.58 |
| EPS Diluted Total Ops | 2.19 | -0.07 | 0.00 | -2.55 | 2.35 |
| EPS Diluted Continuous Ops | -2.92 | -0.07 | 0.00 | 2.55 | -2.58 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.07 | -0.05 | N/A | N/A |
| EBITDA(a) | $-1,148 | $-701 | $-1,118 | $0 | $-1,878 |